|
| Category | FY | Funding IC | Project Number | Project Title | PI Name | Org Name | State / Country | Amount |
|
HIV/AIDS
|
2012
|
FIC
|
|
NIH Other Funding
|
|
|
|
$2,908,609
|
|
HIV/AIDS
|
2012
|
NCATS
|
|
NIH Other Funding
|
|
|
|
$3,416,000
|
|
HIV/AIDS
|
2012
|
NCI
|
|
NIH Other Funding
|
|
|
|
$76,567,027
|
|
HIV/AIDS
|
2012
|
NIMHD
|
|
NIH Other Funding
|
|
|
|
$843,361
|
|
HIV/AIDS
|
2012
|
NHLBI
|
|
NIH Other Funding
|
|
|
|
$3,859,741
|
|
HIV/AIDS
|
2012
|
NIA
|
|
NIH Other Funding
|
|
|
|
$27,972
|
|
HIV/AIDS
|
2012
|
NIAAA
|
|
NIH Other Funding
|
|
|
|
$524,772
|
|
HIV/AIDS
|
2012
|
NIAID
|
|
NIH Other Funding
|
|
|
|
$207,667,700
|
|
HIV/AIDS
|
2012
|
NIAMS
|
|
NIH Other Funding
|
|
|
|
$508,739
|
|
HIV/AIDS
|
2012
|
NICHD
|
|
NIH Other Funding
|
|
|
|
$10,530,441
|
|
HIV/AIDS
|
2012
|
NIDA
|
|
NIH Other Funding
|
|
|
|
$19,925,756
|
|
HIV/AIDS
|
2012
|
NIDCR
|
|
NIH Other Funding
|
|
|
|
$10,000
|
|
HIV/AIDS
|
2012
|
NIEHS
|
|
NIH Other Funding
|
|
|
|
$700,000
|
|
HIV/AIDS
|
2012
|
NIGMS
|
|
NIH Other Funding
|
|
|
|
$202,555
|
|
HIV/AIDS
|
2012
|
NIMH
|
|
NIH Other Funding
|
|
|
|
$13,601,764
|
|
HIV/AIDS
|
2012
|
NINDS
|
|
NIH Other Funding
|
|
|
|
$2,536,415
|
|
HIV/AIDS
|
2012
|
NINR
|
|
NIH Other Funding
|
|
|
|
$131,851
|
|
HIV/AIDS
|
2012
|
NLM
|
|
NIH Other Funding
|
|
|
|
$7,665,000
|
|
HIV/AIDS
|
2012
|
OD
|
|
NIH Other Funding
|
|
|
|
$41,572,105
|
|
HIV/AIDS
|
2012
|
NIDA
|
5R01DA022739-04
|
Healthy Activities for Prize Incentives (HAPI)
|
PETRY, NANCY
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$327,786
|
|
HIV/AIDS
|
2012
|
NIMH
|
5K01MH080660-04
|
HIV Risk Reduction for Women Reporting Intimate Partner Violence
|
MITTAL, MONA
|
UNIVERSITY OF ROCHESTER
|
NY
|
$154,246
|
|
HIV/AIDS
|
2012
|
FIC
|
5G11HD061076-02
|
Strengthening Research Administrative Infrastructure at Univ of Ibadan Nigeria
|
OWOAJE, EME
|
UNIVERSITY OF IBADAN
|
NIGERI
|
$5,000
|
|
HIV/AIDS
|
2012
|
NICHD
|
5R01HD050150-07
|
URBAN CONGREGATIONS' CAPACITY FOR HIV PREVENTION & CARE
|
DEROSE, KATHRYN
|
RAND CORPORATION
|
CA
|
$412,963
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI090866-03
|
Molecular basis of ADCC-mediated HIV protection
|
SUNDBERG, ERIC
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$525,208
|
|
HIV/AIDS
|
2012
|
NIMH
|
5R01MH081772-05
|
The Neuropathobiology of Primary HIV-1 Infection
|
SPUDICH, SERENA
|
YALE UNIVERSITY
|
CT
|
$530,507
|
|
HIV/AIDS
|
2012
|
FIC
|
5R01TW008109-04
|
Hope for the Future: A School-Based HIV Prevention Program for Youth in Malawi
|
KAZEMBE, ABIGAIL
|
KAMUZU COLLEGE OF NURSING
|
MALAWI
|
$51,825
|
|
HIV/AIDS
|
2012
|
NHLBI
|
5R01HL101274-02
|
HIV Disease and Impairement of High Density Lipoprotein Metabolism
|
BUKRINSKY, MICHAEL
|
GEORGE WASHINGTON UNIVERSITY
|
DC
|
$716,126
|
|
HIV/AIDS
|
2012
|
OD
|
1R21AI094666-01
|
Mobile Phone Adherence & Prevention Support for People Living with HIV in India
|
SWENDEMAN, DALLAS
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$180,003
|
|
HIV/AIDS
|
2012
|
NIAID
|
4R37AI030861-17
|
The role of viral and cellular proteins in early events of HIV-1 replication
|
PRASAD, VINAYAKA
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
NY
|
$455,219
|
|
HIV/AIDS
|
2012
|
OD
|
5R01DA026727-02
|
HIV, HCV and Liver Disease Among Injection Drug Users in Chennai, India
|
MEHTA, SHRUTI
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$580,907
|
|
HIV/AIDS
|
2012
|
NIMH
|
5R01MH089266-02
|
Preventing HIV Infection Among MSM in Southern India
|
CELENTANO, DAVID
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$512,492
|
|
HIV/AIDS
|
2012
|
NIAAA
|
5R13AA018630-03
|
Alcohol & HIV in Latin America
|
JAYAWEERA, DUSHYANTHA
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$50,905
|
|
HIV/AIDS
|
2012
|
NICHD
|
5R01HD061930-03
|
Oligosaccharide moieties of human milk glycans that inhibit pathogens
|
NEWBURG, DAVID
|
BOSTON COLLEGE
|
MA
|
$425,496
|
|
HIV/AIDS
|
2012
|
NIDA
|
5R25DA020515-05
|
Resident/Intern Substance Use Research Education (REINSURE)
|
BALL, SAMUEL
|
YALE UNIVERSITY
|
CT
|
$1
|
|
HIV/AIDS
|
2012
|
NIAAA
|
1R21AA020236-01A1
|
The Causal Role of Acute Alcohol Consumption in Risky Sex among HIV-Positive MSM
|
SHUPER, PAUL
|
CENTRE FOR ADDICTION AND MENTAL HEALTH
|
CANADA
|
$141,853
|
|
HIV/AIDS
|
2012
|
NIAID
|
1K22AI095021-01
|
Missed visits and virologic failure among HIV infected African Americans receivin
|
HOWE, CHANELLE
|
BROWN UNIVERSITY
|
RI
|
$153,746
|
|
HIV/AIDS
|
2012
|
NIMH
|
5R01MH065196-10
|
Moving a Research-based Intervention into Practice
|
KEGELES, SUSAN
|
UNIV OF CALIFORNIA AT SAN FRANCISCO
|
CA
|
$494,217
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R33AI079798-05
|
HIV Microbicides and the Vaginal Microbiome
|
ZEICHNER, STEVEN
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$438,399
|
|
HIV/AIDS
|
2012
|
NIGMS
|
2T32GM064337-11
|
Research Training in Chemistry and Chemical Biology
|
CRAIK, CHARLES
|
UNIV OF CALIFORNIA AT SAN FRANCISCO
|
CA
|
$424,588
|
|
HIV/AIDS
|
2012
|
NICHD
|
2R01HD054511-05
|
Sexually Transmitted Infection Epidemics: Bayesian Prevalence and Size Estimates
|
RAFTERY, ADRIAN
|
UNIVERSITY OF WASHINGTON
|
WA
|
$333,473
|
|
HIV/AIDS
|
2012
|
NIDA
|
1R01DA030480-01A1
|
Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients
|
CACCIOLA, JOHN
|
TREATMENT RESEARCH INSTITUTE, INC. (TRI)
|
PA
|
$483,125
|
|
HIV/AIDS
|
2012
|
NIDA
|
1R01DA030351-01A1
|
A Trial to Prevent Opioid Overdose: E.D. Based Intervention & Take-home Naloxone
|
BANTA-GREEN, CALEB
|
UNIVERSITY OF WASHINGTON
|
WA
|
$456,964
|
|
HIV/AIDS
|
2012
|
NIAID
|
4R37AI051178-11
|
Significance of Low Level Viremia in Patients on HAART
|
SILICIANO, ROBERT
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$243,000
|
|
HIV/AIDS
|
2012
|
NIDA
|
1R34DA031063-01A1
|
DVD-based HIV/HCV Intervention for Drug-Involved Latino Criminal Justice Clients
|
IBANEZ, GLADYS
|
UNIVERSITY OF DELAWARE
|
DE
|
$275,400
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI062428-07
|
Antiviral CTL mobilization to the genital mucosa
|
IWASAKI, AKIKO
|
YALE UNIVERSITY
|
CT
|
$414,271
|
|
HIV/AIDS
|
2012
|
NIMH
|
5F31MH090895-02
|
Self-Regulation & Attentional Mechanisms of Sexual Risk Taking in Young Drinkers
|
MACAPAGAL, KATHRYN
|
INDIANA UNIVERSITY BLOOMINGTON
|
IN
|
$42,232
|
|
HIV/AIDS
|
2012
|
NIMH
|
5F31MH093260-02
|
Relationship Power and HIV Testing Behavior in Malawi
|
CONROY, AMY
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$30,958
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069438-06
|
THE IMPACTA PERU CLINICAL TRIALS UNIT
|
SANCHEZ, JORGE
|
ASOCIACION CIVIL IMPACTA SALUD Y EDUCACN
|
PERU
|
$2,376,608
|
|
HIV/AIDS
|
2012
|
NIMH
|
5F31MH090927-02
|
HIV stigma reduction and testing in the Hispanic/Latino Church setting
|
MARTINEZ, DAVID
|
UNIVERSITY OF MISSOURI KANSAS CITY
|
MO
|
$42,232
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069419-06
|
Cornell Clinical Trials Unit
|
GULICK, ROY
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$1,462,527
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069421-06
|
GHESKIO HIV Clinical Trial Unit
|
PAPE, JEAN
|
GHESKIO CENTER
|
HAITI
|
$1,604,865
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069439-06
|
Vanderbilt HIV Clinical Trials Unit
|
HAAS, DAVID
|
VANDERBILT UNIVERSITY MED CTR
|
TN
|
$1,917,163
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI073656-05
|
Interleukin-2 and autoimmune disease
|
ABBAS, ABUL
|
UNIV OF CALIFORNIA AT SAN FRANCISCO
|
CA
|
$378,564
|
|
HIV/AIDS
|
2012
|
NIMH
|
5F30MH085431-04
|
A Randomized Trial of HIV Partner Notification in Malawi
|
BROWN, LILLIAN
|
UNIVERSITY OF N CAROLINA AT CHAPEL HILL
|
NC
|
$23,899
|
|
HIV/AIDS
|
2012
|
NCI
|
5R01CA096735-10
|
t(8;21) and SON in Blood Cell Proliferation and Differentiation
|
ZHANG, DONG-ER
|
UNIVERSITY OF CALIFORNIA AT SAN DIEGO
|
CA
|
$35,857
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI071106-05
|
Alternaria and proteases in innate and adaptive Th2 immunity
|
KITA, HIROHITO
|
MAYO CLINIC
|
MN
|
$373,254
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI087164-03
|
Gene expression biomarkers of immune recovery in HIV infected patients
|
WOELK, CHRISTOPHER
|
VETERANS MEDICAL RESEARCH FDN/SAN DIEGO
|
CA
|
$350,460
|
|
HIV/AIDS
|
2012
|
NCI
|
5R01CA052004-23
|
Control of Gammaherpesvirus Replication
|
SPECK, SAMUEL
|
EMORY UNIVERSITY
|
GA
|
$93,165
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI077417-05
|
Modified Triterpines as Potent HIV Fusion Inhibitors
|
LEE, KUO-HSIUNG
|
UNIVERSITY OF N CAROLINA AT CHAPEL HILL
|
NC
|
$450,507
|
|
HIV/AIDS
|
2012
|
NCI
|
5R01CA138811-03
|
EBV BART miRNAs: Identification of Targets and Characterization of the Effects o
|
RAAB-TRAUB, NANCY
|
UNIVERSITY OF N CAROLINA AT CHAPEL HILL
|
NC
|
$296,590
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI037113-15
|
Structure-Function Studies & Molecular Interactions of Chemokines
|
HANDEL, TRACY
|
UNIVERSITY OF CALIFORNIA AT SAN DIEGO
|
CA
|
$386,771
|
|
HIV/AIDS
|
2012
|
NCI
|
5R01CA131354-04
|
Inhibitors of Epstein-Barr Virus Nuclear Protein 1 Mediated Latent Infection
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$359,276
|
|
HIV/AIDS
|
2012
|
NCI
|
5R01CA080320-13
|
Myc Oncogene Mutations and Polymorphisms in Cancer
|
COLE, MICHAEL
|
DARTMOUTH COLLEGE
|
NH
|
$111,136
|
|
HIV/AIDS
|
2012
|
NIMH
|
5R01MH083568-04
|
Effects of Depression and Its Treatment on the Impact of ART on Health Outcomes
|
WAGNER, GLENN
|
RAND CORPORATION
|
CA
|
$404,702
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI049104-11
|
TAT Transactivation
|
PETERLIN, BORIS
|
UNIV OF CALIFORNIA AT SAN FRANCISCO
|
CA
|
$386,250
|
|
HIV/AIDS
|
2012
|
OD
|
5R01AI049104-11
|
TAT Transactivation
|
PETERLIN, BORIS
|
UNIV OF CALIFORNIA AT SAN FRANCISCO
|
CA
|
$64,376
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI081668-04
|
HIV-1 Vpu and BST-2/CD317
|
GUATELLI, JOHN
|
VETERANS MEDICAL RESEARCH FDN/SAN DIEGO
|
CA
|
$346,955
|
|
HIV/AIDS
|
2012
|
NIMH
|
5R34MH087120-02
|
Internet-Based STI/HIV Prevention for HIV+ Internet Users
|
CRUESS, DEAN
|
UNIVERSITY OF CONNECTICUT STORRS
|
CT
|
$224,730
|
|
HIV/AIDS
|
2012
|
NIAID
|
5K24AI074343-05
|
Interface of Innate and Adaptive Immunity in HIV-1 Infection
|
WILSON, CARA
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$135,004
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI058828-07
|
Role of Vpu in Retroviral Particle Assembly
|
SPEARMAN, PAUL
|
EMORY UNIVERSITY
|
GA
|
$387,500
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI077390-04
|
pH Responsive anti-HIV Nanoparticles
|
HO, RODNEY
|
UNIVERSITY OF WASHINGTON
|
WA
|
$799,505
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI076498-03
|
Protective immunity induced by P. yoelii genetically attenuated vaccines
|
WANG, RUOBING
|
SEATTLE BIOMEDICAL RESEARCH INSTITUTE
|
WA
|
$486,338
|
|
HIV/AIDS
|
2012
|
NIMH
|
5K01MH087242-03
|
HIV/AIDS risk among young men who use the Internet
|
BAUERMEISTER, JOSE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$142,517
|
|
HIV/AIDS
|
2012
|
NIMH
|
5R01MH087462-03
|
Telephone IPT Intervention for HIV-Infected Rural Persons
|
HECKMAN, TIMOTHY
|
OHIO UNIVERSITY ATHENS
|
OH
|
$388,986
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI050468-09
|
Cytomegalovirus virulence in immunodeficient hosts
|
LIU, FENYONG
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$376,113
|
|
HIV/AIDS
|
2012
|
OD
|
5R01AI050468-09
|
Cytomegalovirus virulence in immunodeficient hosts
|
LIU, FENYONG
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$53,458
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI050732-09
|
CD4 T Cells in Tuberculosis
|
FLYNN, JOANNE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$487,620
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI035661-14
|
Vaccine induced immune responses to plasmodial antigens
|
BURNS, JAMES
|
DREXEL UNIVERSITY
|
PA
|
$330,785
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI087452-04
|
Molecular basis of myelomonocytic receptor function in HIV-1 infection
|
SUNDBERG, ERIC
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$384,615
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI073722-05
|
Activation and regulation of autoreactive B cells in health and disease
|
SHLOMCHIK, MARK
|
YALE UNIVERSITY
|
CT
|
$568,221
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI077414-04
|
Define the role of dendritic cells in HTLV-1 associated neuroinflammatory disease
|
JAIN, POOJA
|
DREXEL UNIVERSITY
|
PA
|
$369,890
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI052812-10
|
Immune Receptors on Cytotoxic Lymphocytes and Target Cells
|
SYKULEV, YURI
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$389,223
|
|
HIV/AIDS
|
2012
|
NIAID
|
5K02AI077341-05
|
HIV-1 Integrase Structure and Function as a Therapeutic Target
|
KVARATSKHELIA, MAMUKA
|
OHIO STATE UNIVERSITY
|
OH
|
$98,798
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI085043-03
|
Mechanisms of Viral Persistence
|
BROOKS, DAVID
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$376,165
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI033774-18
|
Protective antibodies for Cryptococcal Infections
|
CASADEVALL, ARTURO
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
NY
|
$410,850
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI067034-06
|
Probing blocks to infectious HIV release in mouse cells
|
SUTTON, RICHARD
|
YALE UNIVERSITY
|
CT
|
$405,516
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI053709-10
|
New infection-related proteins of Plasmodium sporozoites and liver stages
|
KAPPE, STEFAN
|
SEATTLE BIOMEDICAL RESEARCH INSTITUTE
|
WA
|
$377,927
|
|
HIV/AIDS
|
2012
|
NIDCR
|
5R01DE021291-02
|
Efficacy of Oral CMV/SIV Vectors
|
PICKER, LOUIS
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$788,255
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI078775-04
|
PD-1 modulation of SIV specific CD4 and CD8 T cell responses
|
VILLINGER, FRANCOIS
|
EMORY UNIVERSITY
|
GA
|
$465,133
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI080288-04
|
AIDS Lentivirus-induced TGF-beta+ Treg cells Mediate T cell Immune Dysfunction
|
TOMPKINS, MARY
|
NORTH CAROLINA STATE UNIVERSITY RALEIGH
|
NC
|
$365,087
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI091476-02
|
Therapeutic use of an enhanced form of CD4-Ig
|
FARZAN, MICHAEL
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$786,427
|
|
HIV/AIDS
|
2012
|
NCI
|
5R01CA132136-04
|
Entry of Oncogenic HPVs into Human Keratinocytes
|
OZBUN, MICHELLE
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$301,913
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI085073-03
|
Causal inference in infectious disease prevention studies
|
HUDGENS, MICHAEL
|
UNIVERSITY OF N CAROLINA AT CHAPEL HILL
|
NC
|
$314,812
|
|
HIV/AIDS
|
2012
|
NIMH
|
5R01MH083557-04
|
HIV Risk in African MSM is South African Townships
|
SANDFORT, THEODORUS
|
NEW YORK STATE PSYCHIATRIC INSTITUTE
|
NY
|
$564,288
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI049316-10
|
GI Nematodes and Gut Functional Responses to Inflammation
|
SHEA-DONOHUE, TEREZ
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$367,538
|
|
HIV/AIDS
|
2012
|
NIMH
|
5K23MH082641-05
|
Adherence to HIV Care: Advancing the Science
|
MUGAVERO, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$176,175
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069465-06
|
Johns Hopkins AIDS Clinical Trials Unit
|
FLEXNER, CHARLES
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$1,698,051
|
|
HIV/AIDS
|
2012
|
NCI
|
5R01CA119917-05
|
Studying the role of KSHV-encoded microRNAs
|
RENNE, ROLF
|
UNIVERSITY OF FLORIDA
|
FL
|
$286,093
|
|
HIV/AIDS
|
2012
|
NIMH
|
5R01MH069133-09
|
Transitioning from childhood to adulthood: the impact of perinatal HIV infection
|
MELLINS, CLAUDE
|
NEW YORK STATE PSYCHIATRIC INSTITUTE
|
NY
|
$666,783
|
|
HIV/AIDS
|
2012
|
NIAID
|
5F31AI077321-04
|
Interaction of HIV with Macaque Genital Tract
|
CARIAS, ANN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$29,170
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069432-06
|
UCSD Department of Medicine HIV/AIDS Clinical Trials Unit
|
BENSON, CONSTANCE
|
UNIVERSITY OF CALIFORNIA AT SAN DIEGO
|
CA
|
$2,919,144
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI078773-04
|
Innate Immunity and SIV Infection
|
ANSARI, AFTAB
|
EMORY UNIVERSITY
|
GA
|
$2,143,058
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069423-06
|
University of North Carolina AIDS Clinical Trials Unit (UNC ACTU)
|
ERON, JOSEPH
|
UNIVERSITY OF N CAROLINA AT CHAPEL HILL
|
NC
|
$2,133,622
|
|
HIV/AIDS
|
2012
|
NIDA
|
5UM1AI069423-06
|
University of North Carolina AIDS Clinical Trials Unit (UNC ACTU)
|
ERON, JOSEPH
|
UNIVERSITY OF N CAROLINA AT CHAPEL HILL
|
NC
|
$1,103,245
|
|
HIV/AIDS
|
2012
|
NIDCR
|
5R01DE021223-02
|
Oral immunization against HIV/AIDS with prime-boost strategies
|
HU, SHIU-LOK
|
UNIVERSITY OF WASHINGTON
|
WA
|
$489,040
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI047798-12
|
PLASMEPSIN V FUNCTION IN MALARIA PARASITES
|
GOLDBERG, DANIEL
|
WASHINGTON UNIVERSITY
|
MO
|
$157,500
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069447-06
|
Institute of Human Virology Clinical Trials Unit
|
DAVIS, CHARLES
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$769,068
|
|
HIV/AIDS
|
2012
|
OD
|
5UM1AI069447-06
|
Institute of Human Virology Clinical Trials Unit
|
DAVIS, CHARLES
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$19,200
|
|
HIV/AIDS
|
2012
|
NHLBI
|
5R01HL088989-05
|
Role of B cells in host defense against Pneumocystis
|
GARVY, BETH
|
UNIVERSITY OF KENTUCKY
|
KY
|
$366,250
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI056045-07
|
Uncovering the Regulatory Role of gH/gL in HSV Fusion
|
EISENBERG, ROSELYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$400,000
|
|
HIV/AIDS
|
2012
|
NIMH
|
5R01MH084794-03
|
Memory Functioning in Children and Adolescents with Perinatal HIV Infection
|
NICHOLS, SHARON
|
UNIVERSITY OF CALIFORNIA AT SAN DIEGO
|
CA
|
$410,757
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069532-06
|
New York University HIV/AIDS Clinical Trial Unit
|
ABERG, JUDITH
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$1,460,503
|
|
HIV/AIDS
|
2012
|
NIAID
|
5K08AI071724-05
|
Evolution of Dendritic Cell Dysfunction in FIV Infection
|
WEBB, TRACY
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
CO
|
$111,305
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069418-06
|
Emory HIV/AIDS Clinical Trials Unit
|
LENNOX, JEFFREY
|
EMORY UNIVERSITY
|
GA
|
$1,952,108
|
|
HIV/AIDS
|
2012
|
NINR
|
5R01NR010860-04
|
Reducing Urban Women's HIV Risk: Soap Opera Videos on Video Capable Cell Phones
|
JONES, RACHEL
|
RUTGERS THE STATE UNIV OF NJ NEWARK
|
NJ
|
$394,119
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI081581-03
|
Novel Assay for HIV-1 Integrase Inhibitors
|
KVARATSKHELIA, MAMUKA
|
OHIO STATE UNIVERSITY
|
OH
|
$377,438
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069450-06
|
Colorado AIDS Clinical Trials Unit
|
CAMPBELL, THOMAS
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$1,160,608
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069441-06
|
Baylor College of Medicine Clinical Trial Unit
|
SHEARER, WILLIAM
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$959,712
|
|
HIV/AIDS
|
2012
|
NIMHD
|
5R01MD004075-03
|
Reducing Risk of HIV/STD Infection Among African American Men
|
JEMMOTT, JOHN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$396,000
|
|
HIV/AIDS
|
2012
|
NIGMS
|
5R01GM066682-08
|
MECHANISMS OF HIV-1 MEMBRANE FUSION
|
ROOT, MICHAEL
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$446,400
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069428-06
|
UNIVERSITY OF SOUTHERN CALIFORNIA CLINICAL TRIALS UNIT
|
SATTLER, FRED
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$1,734,887
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069511-06
|
Units for HIV/AIDS Clinical Trials Networks
|
KEEFER, MICHAEL
|
UNIVERSITY OF ROCHESTER
|
NY
|
$2,158,520
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069415-06
|
University of Puerto Rico Clinical Trials Unit
|
ZORRILLA, CARMEN
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
PR
|
$2,397,451
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069495-06
|
WASHINGTON UNIVERSITY AIDS CLINICAL TRIALS UNIT
|
CLIFFORD, DAVID
|
WASHINGTON UNIVERSITY
|
MO
|
$1,518,094
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069556-06
|
Stanford AIDS Clinical Trials Unit
|
ZOLOPA, ANDREW
|
STANFORD UNIVERSITY
|
CA
|
$1,091,817
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI088075-02
|
Characterization of Pupylation in Mycobacterium tuberculosis
|
DARWIN, KATERINA
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$380,250
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069494-06
|
University of Pittsburgh Clinical Trials Unit
|
MELLORS, JOHN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$2,474,261
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069537-06
|
NJMS Clinical Trials Unit: Targeting Pediatric, Adolescent, and Material HIV Infe
|
OLESKE, JAMES
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$600,868
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069477-06
|
Miami HIV/AIDS Clinical Therapeutic and Vaccine Trial Unit
|
FISCHL, MARGARET
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$1,173,611
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069470-06
|
Columbia Collaborative HIV/AIDS Clinical Trials Unit
|
HAMMER, SCOTT
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$2,644,556
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI031478-20
|
Mechanisms of mosquito midgut invasion by Plasmodium ookinetes
|
JACOBS-LORENA, MARCELO
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$401,841
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069484-06
|
HIV/AIDS Clinical Trials Unit
|
BARTLETT, JOHN
|
DUKE UNIVERSITY
|
NC
|
$2,613,765
|
|
HIV/AIDS
|
2012
|
NIMH
|
5R01MH093271-02
|
Regulation of HIV-1 by Rad51 in CNS cells
|
KHALILI, KAMEL
|
TEMPLE UNIVERSITY
|
PA
|
$382,500
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069472-06
|
Partners Healthcare Systems/Harvard Medical School/Boston Medical Center AIDS CTU
|
KURITZKES, DANIEL
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$3,226,409
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069413-06
|
Bronx-Lebanon Hospital Clinical Trials Unit
|
PURSWANI, MURLI
|
BRONX-LEBANON HOSP CTR (BRONX, NY)
|
NY
|
$685,005
|
|
HIV/AIDS
|
2012
|
NIGMS
|
5R01GM062920-14
|
Activity of Resistant Variants of HIV Protease
|
WEBER, IRENE
|
GEORGIA STATE UNIVERSITY
|
GA
|
$318,656
|
|
HIV/AIDS
|
2012
|
NIGMS
|
5R01GM052072-16
|
Regulation of Retrotransposition in S. cerevisiae
|
CURCIO, M JOAN
|
WADSWORTH CENTER
|
NY
|
$314,347
|
|
HIV/AIDS
|
2012
|
NCI
|
5R01CA137894-04
|
EBV Antigen and Cell Cycle Regulation
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$285,308
|
|
HIV/AIDS
|
2012
|
NCI
|
5R01CA035299-29
|
Signal Transduction in T Lymphocyte Activation
|
ALTMAN, AMNON
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
CA
|
$153,065
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069512-06
|
Units for HIV/AIDS Clinical Trials Networks
|
YOGEV, RAM
|
LURIE CHILDREN'S HOSPITAL OF CHICAGO
|
IL
|
$1,523,588
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069501-06
|
Case AIDS Clinical Trials Unit
|
LEDERMAN, MICHAEL
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$3,176,040
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069436-06
|
UZ-UCSF Clinical Trials Unit
|
CHIRENJE, ZVAVAHERA
|
UNIV OF CALIFORNIA AT SAN FRANCISCO
|
CA
|
$4,083,626
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069424-06
|
UCLA AIDS Prevention and Treatment Clinical Trials Unit
|
CURRIER, JUDITH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$4,216,430
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069451-06
|
University of Miami Pediatric Perinatal HIV/AIDS Clinical Trails Unit
|
SCOTT, GWENDOLYN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$2,155,675
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069467-06
|
Philadelphia IMPAACT Clinical Trials Unit
|
DOUGLAS, STEVEN
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
PA
|
$1,922,500
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R21AI093175-02
|
CELLULAR RESTRICTIVE FACTOR TARGETED BY VIRAL PROTEIN X
|
RATNER, LEE
|
WASHINGTON UNIVERSITY
|
MO
|
$228,000
|
|
HIV/AIDS
|
2012
|
NIDCR
|
5R01DE021273-02
|
Attenuated RhCMV Delta 10 SIV Oral Vaccine Vectors Encoding TLR5 Ligand Sequences
|
SPARGER, ELLEN
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$616,708
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069474-06
|
The Ohio State University AIDS Clinical Trials Unit
|
KOLETAR, SUSAN
|
OHIO STATE UNIVERSITY
|
OH
|
$1,871,585
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069513-06
|
University of Cincinnati AIDS Clinical Trials Unit- UC ACTU
|
FICHTENBAUM, CARL
|
UNIVERSITY OF CINCINNATI
|
OH
|
$1,668,393
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069471-06
|
Northwestern University Clinical Trial Unit
|
MURPHY, ROBERT
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$2,628,944
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069456-06
|
Botswana-Harvard School of Public Health AIDS Initiative Partnership CTU
|
ESSEX, MYRON
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
MA
|
$2,772,513
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069480-05
|
Clinical Trial Unit for HIV Prevention and Microbicide Research
|
MAYER, KENNETH
|
FENWAY COMMUNITY HEALTH CENTER
|
MA
|
$1,229,912
|
|
HIV/AIDS
|
2012
|
NIAID
|
7UM1AI069455-06
|
Centre for Infectious Diseases Research in Zambia HIV/AIDS Clinical Trials Unit
|
STRINGER, JEFFREY
|
UNIVERSITY OF N CAROLINA AT CHAPEL HILL
|
NC
|
$1,514,808
|
|
HIV/AIDS
|
2012
|
NIMH
|
7UM1AI069455-06
|
Centre for Infectious Diseases Research in Zambia HIV/AIDS Clinical Trials Unit
|
STRINGER, JEFFREY
|
UNIVERSITY OF N CAROLINA AT CHAPEL HILL
|
NC
|
$54,000
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069529-06
|
St. Jude/Memphis IMPAACT Clinical Trials Unit (Composite)
|
FLYNN, PATRICIA
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$1,189,565
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069518-06
|
The Malawi Clinical Trials Unit
|
TAHA, TAHA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$5,410,755
|
|
HIV/AIDS
|
2012
|
NIMH
|
5UM1AI069518-06
|
The Malawi Clinical Trials Unit
|
TAHA, TAHA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$54,000
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069452-06
|
Alabama-Clinical Trials Unit
|
SAAG, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$1,856,693
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI087181-03
|
Broadly Neutralizing Monoclonal Antibodies Against HIV-1
|
LEWIS, GEORGE
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$547,121
|
|
HIV/AIDS
|
2012
|
NIMH
|
5R01MH069934-08
|
Community partnerships to prevent urban youth health risks (CHAMPions)
|
MCKAY, MARY
|
MOUNT SINAI SCHOOL OF MEDICINE
|
NY
|
$714,710
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069516-06
|
Western New England Maternal Pediatric Adolescent AIDS Clinical Trials Unit
|
LUZURIAGA, KATHERINE
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$766,714
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI087915-02
|
Host determinants of protection against tuberculosis in adolescents
|
HANEKOM, WILLEM
|
UNIVERSITY OF CAPE TOWN
|
SO AFR
|
$667,142
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R21AI090434-02
|
Effects of mycobacterial infections induced cell death on host immune response
|
LEE, SUNHEE
|
DUKE UNIVERSITY
|
NC
|
$196,250
|
|
HIV/AIDS
|
2012
|
NIMH
|
5K24MH093225-02
|
Positive Affect Regulation for HIV Prevention in People with Mood Disorders
|
MOSKOWITZ, JUDITH
|
UNIV OF CALIFORNIA AT SAN FRANCISCO
|
CA
|
$144,098
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R21AI092074-02
|
Transgenic mouse models of HCV infection and replication
|
JIANG, JIEYUN
|
UNIVERSITY OF KENTUCKY
|
KY
|
$222,750
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R03AI089352-02
|
A Humanized mouse model lacking a-gal epitopes and producing anti-Gal antibodies
|
ABDEL-MOTAL, USSAMA
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$77,188
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI093319-02
|
Antifibrotic Therapy to Improve Immune reconstitution in HIV
|
SCHACKER, TIMOTHY
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$692,430
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI091790-02
|
Biotin synthesis and biotin ligation in Mtb
|
SCHNAPPINGER, DIRK
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$605,531
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI092573-02
|
Drug targets in Mtb Gluconeogenesis
|
EHRT, SABINE
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$607,211
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069434-06
|
UW Clinical HIV Integrated Research Program
|
COLLIER, ANN
|
UNIVERSITY OF WASHINGTON
|
WA
|
$1,255,138
|
|
HIV/AIDS
|
2012
|
NIMH
|
5K23MH086338-03
|
Peer health workers: Impact on retention, care and secondary prevention of PLHIV
|
CHANG, LARRY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$182,790
|
|
HIV/AIDS
|
2012
|
NHLBI
|
5R01HL059842-15
|
Synergy of Host Defense Mechanisms in the Lung
|
CASADEVALL, ARTURO
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
NY
|
$373,500
|
|
HIV/AIDS
|
2012
|
NCI
|
5R01CA117830-07
|
Regulation of KSHV Latency
|
LIEBERMAN, PAUL
|
WISTAR INSTITUTE
|
PA
|
$291,966
|
|
HIV/AIDS
|
2012
|
NIMH
|
5R01MH085594-03
|
Web-Based Middle School HIV Prevention Curricula: Aspiring for Reach and Impact
|
PESKIN, MELISSA
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$574,527
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069401-06
|
UCLA Los Angeles Brazil AIDS Consortium
|
BRYSON, YVONNE
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$1,510,080
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R21AI092316-02
|
DlaT as a transcriptional regulator in non-replicating Mycobacterium tuberculosis
|
BRYK, RUSLANA
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$213,571
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI075099-05
|
Role of HCV p7 and NS2 in infectious virus production
|
RICE, CHARLES
|
ROCKEFELLER UNIVERSITY
|
NY
|
$414,092
|
|
HIV/AIDS
|
2012
|
NIMH
|
5K23MH081786-05
|
Calibrated BOLD fMRI of HIV Associated Neurocognitive Impairment (HNCI)
|
ANCES, BEAU
|
WASHINGTON UNIVERSITY
|
MO
|
$159,368
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R21AI092230-02
|
HSV encoded viral functions
|
HE, BIN
|
UNIVERSITY OF ILLINOIS
|
IL
|
$190,504
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI077401-04
|
Targeting PI3K/Akt Cell Survival Pathway as a Novel Anti-HIV Therapy
|
KIM, BAEK
|
UNIVERSITY OF ROCHESTER
|
NY
|
$339,605
|
|
HIV/AIDS
|
2012
|
NINR
|
5R21NR012663-02
|
Evaluation of antiretroviral HIV prevention in African HIV discordant couples
|
BAETEN, JARED
|
UNIVERSITY OF WASHINGTON
|
WA
|
$174,230
|
|
HIV/AIDS
|
2012
|
NIGMS
|
5P01GM083658-05
|
Resistance Driven Structural Design for HIV Therapies
|
OLSON, ARTHUR
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$1,469,024
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI073098-05
|
Elucidation of HIV Env acquisition strategies
|
JOHNSON, MARC
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
MO
|
$292,272
|
|
HIV/AIDS
|
2012
|
NCI
|
5R01CA066519-18
|
EBV-based Strategies for AIDS-related Malignancies
|
KENNEY, SHANNON
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$261,708
|
|
HIV/AIDS
|
2012
|
NIMH
|
5R01MH078757-03
|
Emotional-behavior disorders in South African children affected by AIDS
|
SHARP, CARLA
|
UNIVERSITY OF HOUSTON
|
TX
|
$270,629
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI081600-04
|
Intermolecular cooperativity in the action of antiviral agents
|
SILICIANO, ROBERT
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$281,290
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI080129-05
|
Decryption of KIR genetics and function in early HIV-1 infection
|
BARBOUR, JASON
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$721,269
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI026756-24
|
Treponema pallidum Outer Membrane Proteins and Transition Metal Acquisition
|
RADOLF, JUSTIN
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$483,247
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R37AI040357-17
|
Development of VSV/HIV Recombinants as HIV Vaccines
|
ROSE, JOHN
|
YALE UNIVERSITY
|
CT
|
$324,413
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI081625-03
|
Monitoring the development of anti-Env Abs during HIV infection
|
STAMATATOS, LEONIDAS
|
SEATTLE BIOMEDICAL RESEARCH INSTITUTE
|
WA
|
$487,479
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI073335-05
|
RNA-dependent RNA Synthesis by the Hepatitis C Virus
|
KAO, CHENG
|
INDIANA UNIVERSITY BLOOMINGTON
|
IN
|
$296,987
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI083279-03
|
Regulation of T cell development and maturation by NKAP
|
SHAPIRO, VIRGINIA
|
MAYO CLINIC
|
MN
|
$373,973
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI087917-03
|
HCV NS4B: Translating molecular virology into novel antiviral therapies
|
GLENN, JEFFREY
|
STANFORD UNIVERSITY
|
CA
|
$396,363
|
|
HIV/AIDS
|
2012
|
NIDDK
|
5K24DK064545-10
|
Strategies to Improve CAD Risk In HIV Disease
|
GRINSPOON, STEVEN
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$153,613
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI073713-05
|
Behavioral and Virologic Impact of HPV Immunization
|
KAHN, JESSICA
|
CHILDREN'S HOSPITAL MEDICAL CENTER CINCI
|
OH
|
$501,511
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R37AI047365-13
|
Structure and Function of the Hepatitis C Virus Genome
|
SARNOW, PETER
|
STANFORD UNIVERSITY
|
CA
|
$435,131
|
|
HIV/AIDS
|
2012
|
NIMHD
|
5R01MD004065-03
|
HIV Prevention among African Americans: A Media Campaign
|
ADIMORA, ADAORA
|
UNIVERSITY OF N CAROLINA AT CHAPEL HILL
|
NC
|
$321,631
|
|
HIV/AIDS
|
2012
|
NIMH
|
5K25MH089851-03
|
Manganese Enhanced Multi-MRI for Murine HIV-1 Associated Neurocognitive Disorders
|
LIU, YUTONG
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
NE
|
$139,553
|
|
HIV/AIDS
|
2012
|
NIMH
|
5R01MH085608-04
|
Mannose Binding Lectin in Neuroinflammation and NeuroAIDS
|
SINGH, KUMUD
|
UNIVERSITY OF CALIFORNIA AT SAN DIEGO
|
CA
|
$363,268
|
|
HIV/AIDS
|
2012
|
NIMH
|
5R01MH056838-16
|
Platelet Activating Factor, Synaptic Failure & NeuroAIDS
|
GELBARD, HARRIS
|
UNIVERSITY OF ROCHESTER
|
NY
|
$362,093
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069420-05
|
Sao Paulo Clinical Trials Unit
|
KALLAS, ESPER
|
FUNDACAO FACULDADE DE MEDICINA
|
BRAZIL
|
$405,024
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R37AI047367-13
|
HCV-specific T cell response
|
WALKER, CHRISTOPHER
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$662,172
|
|
HIV/AIDS
|
2012
|
OD
|
5R37AI047367-13
|
HCV-specific T cell response
|
WALKER, CHRISTOPHER
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$43,792
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R21AI093243-02
|
Rational design of indole compounds as HIV fusion inhibitors
|
GOCHIN, MIRIAM
|
TOURO UNIVERSITY OF CALIFORNIA
|
CA
|
$180,875
|
|
HIV/AIDS
|
2012
|
NIDA
|
5R01DA013137-12
|
HIV/Cocaine Neurotoxicity in Females
|
BOOZE, ROSEMARIE
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
SC
|
$362,500
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI071084-04
|
Probing the antibody response to HCV to facilitate rational immunogen design
|
BURTON, DENNIS
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$621,118
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI081651-03
|
Role of Tat and SIRT1 in the T-cell Hyperactivation Syndrome Induced by HIV-1
|
OTT, MELANIE
|
J. DAVID GLADSTONE INSTITUTES
|
CA
|
$472,725
|
|
HIV/AIDS
|
2012
|
FIC
|
5K01TW008410-03
|
Evidence-based mental health assessment and treatment for HIV prevention in Kenya
|
HARDER, VALERIE
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
VT
|
$57,014
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI069000-07
|
Roles for microRNA-122 in hepatitis C virus RNA amplification
|
SARNOW, PETER
|
STANFORD UNIVERSITY
|
CA
|
$391,459
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI080290-03
|
Origin and Evolution of HIV-1 Drug Resistance in the RT-SHIVmne Macaque Model
|
AMBROSE, ZANDREA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$213,679
|
|
HIV/AIDS
|
2012
|
NCI
|
5R37CA030488-32
|
Construction and Analysis of Retrovirus Mutants
|
GOFF, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$189,142
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI071121-05
|
Determinants of growth and fitness in drug resistant malaria parasites
|
FERDIG, MICHAEL
|
UNIVERSITY OF NOTRE DAME
|
IN
|
$359,195
|
|
HIV/AIDS
|
2012
|
NCI
|
5R01CA142362-03
|
Regulation of the Tumor Microenvironment by KSHV
|
PARSONS, CHRISTOPHER
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$296,881
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069412-06
|
Harvard Medical School Vaccine Clinical Trials Unit
|
DOLIN, RAPHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$1,095,523
|
|
HIV/AIDS
|
2012
|
NCI
|
5R01CA065883-17
|
Epstein Barr Virus Latency
|
THORLEY-LAWSON, DAVID
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$335,732
|
|
HIV/AIDS
|
2012
|
NIMH
|
5K01MH080649-05
|
HIV Prevention and Partner Abuse: Developing an Intervention for Adolescent Girls
|
TEITELMAN, ANNE
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$165,396
|
|
HIV/AIDS
|
2012
|
NIMH
|
5K01MH089729-03
|
Faith-based HIV Prevention Intervention for African American Mothers and Daughter
|
KAPUNGU, CHISINA
|
UNIVERSITY OF ILLINOIS
|
IL
|
$166,335
|
|
HIV/AIDS
|
2012
|
NIMH
|
5R01MH086329-03
|
A Parenting Intervention for HIV+ Moms: The IMAGE program
|
MURPHY, DEBRA
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$502,762
|
|
HIV/AIDS
|
2012
|
NCI
|
5R01CA122539-05
|
Lymphoproliferative Disorders in Primary Immunodeficiencies
|
ROUTES, JOHN
|
MEDICAL COLLEGE OF WISCONSIN
|
WI
|
$314,363
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI038201-15
|
HIV 1 Nef and Viral Infectivity
|
GUATELLI, JOHN
|
VETERANS MEDICAL RESEARCH FDN/SAN DIEGO
|
CA
|
$378,663
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI072142-07
|
Molecular Recognition Studies of the Interleukin-7 Pathway
|
WALSH, SCOTT
|
UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS
|
MD
|
$294,030
|
|
HIV/AIDS
|
2012
|
NCI
|
5R01CA129560-04
|
Disruption of HLA Class II-Mediated Immune Recognition of B-Cell Lymphomas
|
HAQUE, AZIZUL
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$296,881
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI044115-13
|
Interactions and mechanisms of function of the TAP complex
|
RAGHAVAN, MALINI
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$378,474
|
|
HIV/AIDS
|
2012
|
NCI
|
5R37CA042245-27
|
Regulation of replication and latency EBV EBNAs
|
HAYWARD, S
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$356,292
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069496-06
|
San Francisco Vaccine and Prevention Unit
|
BUCHBINDER, SUSAN
|
PUBLIC HEALTH FOUNDATION ENTERPRISES
|
CA
|
$1,374,560
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069406-06
|
Southern Asia HIV/AIDS Clinical Trials Unit
|
CELENTANO, DAVID
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$478,658
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI087734-02
|
LIGHT_HVEM_BTLA axis in protective anti_viral immunity
|
SALEK-ARDAKANI, SHAHRAM
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
CA
|
$363,600
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI064768-07
|
Biology of lipoamide dehydrogenase and 2-hydroxy-3-oxoadipate synthase in Mtb
|
NATHAN, CARL
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$919,954
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI071223-05
|
Experimental Molecular Vaccines for Schistosomiasis
|
SIDDIQUI, AFZAL
|
TEXAS TECH UNIVERSITY HEALTH SCIS CENTER
|
TX
|
$359,121
|
|
HIV/AIDS
|
2012
|
NINDS
|
5R01NS038836-14
|
Defense mechanisms against CMV brain infection
|
LOKENSGARD, JAMES
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$323,706
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069481-06
|
Seattle Vaccine Trials Unit
|
MCELRATH, MARGARET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$592,662
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI044616-14
|
Computer-Aided Design of Anti-HIV Drugs
|
JORGENSEN, WILLIAM
|
YALE UNIVERSITY
|
CT
|
$324,413
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069502-06
|
UCSF HIV Clinical Trials Unit
|
HAVLIR, DIANE
|
UNIV OF CALIFORNIA AT SAN FRANCISCO
|
CA
|
$6,132,107
|
|
HIV/AIDS
|
2012
|
NIAID
|
5U01AI069486-06
|
Development of HIV Vaccine Clinical Trials Phase I-II-III in Dominican Republic
|
DONASTORG, YEYCY
|
INSTITUTO DERMATOLOGICO CIRUGIA DE PIEL
|
DOM RE
|
$182,465
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R21AI092448-02
|
Defining the Correlates of Bactericidal Immunity in Tuberculosis
|
PORCELLI, STEVEN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
NY
|
$208,125
|
|
HIV/AIDS
|
2012
|
OD
|
8U42OD012210-13
|
UCD Mutant Mouse Regional Resource Center
|
LLOYD, KC
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$297,164
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI087135-03
|
Estimation Methods for Nonlinear ODE Models in AIDS Research
|
WU, HULIN
|
UNIVERSITY OF ROCHESTER
|
NY
|
$344,149
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI087746-03
|
Cyclophilins, Cyclophilin Inhibitors and Hepatitis C
|
GALLAY, PHILIPPE
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$470,003
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI087658-02
|
Mapping eQTLs that affect susceptibility to Tuberculosis
|
GILAD, YOAV
|
UNIVERSITY OF CHICAGO
|
IL
|
$590,585
|
|
HIV/AIDS
|
2012
|
NICHD
|
5R01HD068174-02
|
Antimalarial Pharmacology in HIV Coinfected Children and Pregnant Women in Uganda
|
AWEEKA, FRANCESCA
|
UNIV OF CALIFORNIA AT SAN FRANCISCO
|
CA
|
$535,652
|
|
HIV/AIDS
|
2012
|
NIMH
|
5R01MH084724-04
|
HIV Prevention Through Multilevel Intervention to Promote Women-Initiated Options
|
WEEKS, MARGARET
|
INSTITUTE FOR COMMUNITY RESEARCH
|
CT
|
$754,698
|
|
HIV/AIDS
|
2012
|
NIMH
|
5R01MH083594-04
|
Environmental/Behavioral Factors Shaping Circumcision Decisions in Zimbabwe
|
MONTANO, DANIEL
|
BATTELLE CENTERS/PUB HLTH RES & EVALUATN
|
OH
|
$632,655
|
|
HIV/AIDS
|
2012
|
NIMH
|
5R01MH093241-02
|
Social Cash Transfers, Household Risk and HIV Prevention in Kenya
|
HANDA, SUDHANSHU
|
UNIVERSITY OF N CAROLINA AT CHAPEL HILL
|
NC
|
$333,208
|
|
HIV/AIDS
|
2012
|
NIMH
|
5K08MH085566-04
|
Culturally Relevant HIV Prevention for High-Risk Women
|
SEVELIUS, JEANNE
|
UNIV OF CALIFORNIA AT SAN FRANCISCO
|
CA
|
$166,535
|
|
HIV/AIDS
|
2012
|
NCI
|
5R37CA031798-32
|
LYMPHOCYTE FUNCTION ASSOCIATED ANTIGENS
|
SPRINGER, TIMOTHY
|
IMMUNE DISEASE INSTITUTE, INC.
|
MA
|
$483,850
|
|
HIV/AIDS
|
2012
|
NCI
|
5R01CA047752-23
|
Mechanisms of Natural Killer Cell Activation
|
BILLADEAU, DANIEL
|
MAYO CLINIC
|
MN
|
$151,372
|
|
HIV/AIDS
|
2012
|
NIAID
|
5R01AI043198-14
|
Mechanisms of innate immunity against HIV
|
RANA, TARIQ
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
CA
|
$472,725
|
|
HIV/AIDS
|
2012
|
NIAID
|
5UM1AI069534-06
|
Penn prevention clinical trials unit
|
METZGER, DAVID
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$616,277
|
|
HIV/AIDS
|
2012
|
NIMH
|
5R01MH049981-18
|
Tachykinins Mononuclear Phagocytes and HIV-1 Infection
|
DOUGLAS, STEVEN
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
PA
|
$386,781
|
|
HIV/AIDS
|
2012
|
NIDDK
|
5R01DK061297-09
|
HIV reservoir and CD4 repopulation in gut lymphoid tissue
|
DANDEKAR, SATYA
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$359,931
|
|
|
